Advertisement

Topics

Search Results for "Quantos Anos Dura O Curso De Farmacia"

11:38 EDT 26th April 2017 | BioPortfolio

Matching Channels

None

Matching News

Invivoscribe Amplia Menu da Plataforma Ion PGM(TM) NGS: Novos Kits de Clonalidade CE-IVD com ...

SAN DIEGO, CA--(Marketwired - Feb 28, 2017) - A Invivoscribe(R) Technologies Inc., uma empresa global com mais de 20 anos de experiência com fornecimento Read more...

Invivoscribe anuncia assinatura de Contrato de Colabora??o de Longo Prazo com a Illumina e ...

SAN DIEGO, CA--(Marketwired - Feb 14, 2017) - A Invivoscribe(R) Technologies Inc., uma empresa global com mais de 20 anos de experiência com fornecimento Read more...

A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes

Juan Cadiñanos and colleagues perform an insertional mutagenesis screen with a single-copy inactivating Sleeping Beauty transposon to look for Pten-cooperating tumor suppressor genes in mice. They fi...

Algunos pacientes diabéticos de la tercera edad enfrentan altos costos de medicamentos

Por Lisa Rapaport (Reuters Health) - A pesar de los esfuerzos recientes parareducir las cuentas de la farmacia de los adultos mayores deEstados Unidos, un estudio indica que muchos pacientes condiabet...

Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration in India

Dr. Reddy's Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, ann...

PvP Biologics Announces Leadership Team

SAN DIEGO and SEATTLE, Jan. 5, 2017 /PRNewswire/ -- PvP Biologics today announced the company's leadership team.  The company was formed to advance an oral enzyme therapy, called KumaMax, for the...

Kerecis ehf Medical Equipment Deals and Alliances Profile [Updated: 24012017] Prices from USD $250

SummaryKerecis ehf is a biotechnology and medical device company. Its flagship Kerecis Omega3 fishskin acellular dermal matrix transplantation technology is intended for use in products to treat acute...

Kerecis ehf Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 20032017] Prices from USD $250

SummaryKerecis ehf is a biotechnology and medical device company. Its flagship Kerecis Omega3 fishskin acellular dermal matrix transplantation technology is intended for use in products to treat acute...

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement